News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kraws Jeffrey J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.3314, valued at
$66.3k
|
|
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Granted 200 shares
@ $5.4315, valued at
$1.1k
|
|
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2020 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Bought 10,000 shares
@ $0.46, valued at
$4.6k
|
|
| 12/26/2019 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Paid exercise price by delivering 792 shares
@ $0.901, valued at
$713.6 |
|
| 12/06/2019 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 250,000 options
@ $0.418, valued at
$104.5k
|
|
| 12/05/2019 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Paid exercise price by delivering 38,372 shares
@ $1.8219, valued at
$69.9k
Granted 139,052 options to buy
@ $1.22, valued at
$169.6k
|
|
| 07/23/2019 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Sold 11,930 shares
@ $2.9314, valued at
$35k
|
|
| 06/17/2019 |
4
| Kraws Jeffrey J (Co-President) has filed a Form 4 on Ra Medical Systems, Inc.|
Txns:
| Sold 18,021 shares
@ $3.0763, valued at
$55.4k
|
|
| 04/10/2019 |
3
| Kraws Jeffrey J (Director) has filed a Form 3 on Saleen Automotive, Inc. |
| 12/07/2018 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 79,500 options
@ $0.6895, valued at
$54.8k
|
|
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/21/2017 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 200,000 options
@ $0.52, valued at
$104k
|
|
| 03/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2015 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 125,000 options
@ $2.76, valued at
$345k
|
|
| 08/14/2014 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Saleen Automotive, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.1, valued at
$50k
|
|
| 04/21/2014 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on Synthetic Biologics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.52, valued at
$264.6k
|
|
| 10/24/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2011 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on ADEONA PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options
@ $1.5, valued at
$37.5k
|
|
| 12/03/2010 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on ADEONA PHARMACEUTICALS, INC.|
Txns:
| Granted 8,333 options
@ $0.74, valued at
$6.2k
|
|
| 03/25/2010 |
4
| Kraws Jeffrey J (Director) has filed a Form 4 on ADEONA PHARMACEUTICALS, INC.|
Txns:
| Granted 8,333 options to buy
@ $0.53, valued at
$4.4k
|
|
| 11/17/2006 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|